Tomasicchio, Michele <br/><br/>
An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Jan 2019 
 - 71-83 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-018-2238-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Breast Neoplasms--immunology<br/>Cancer Vaccines--immunology<br/>Coculture Techniques<br/>Cytokines--immunology<br/>Dendritic Cells--immunology<br/>Female<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Lymphocyte Activation--immunology<br/>Middle Aged<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Th1 Cells--immunology<br/>Tumor Cells, Cultured